Cargando…

Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids

INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is a multifactorial disease. As a clinical empirical prescription of traditional Chinese medicine, Qushi Huayu decoction (QHD) has attracted considerable attention for its advantages in multi-target treatment of NAFLD. However, the intervention...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Yiming, Wang, Xin, Wu, Qian, Yao, Yichen, Xu, Yuan, Li, Yuanyuan, Feng, Qin, Zhou, Mingmei, Gou, Xiaojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600383/ https://www.ncbi.nlm.nih.gov/pubmed/37900123 http://dx.doi.org/10.3389/fendo.2023.1272214

Ejemplares similares

Qushi Huayu Decoction Inhibits Hepatic Lipid Accumulation by Activating AMP-Activated Protein Kinase In Vivo and In Vitro
por: Feng, Qin, et al.
Publicado: (2013)

Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology
por: Gao, Shan-shan, et al.
Publicado: (2020)

A Metabolomic Study on the Intervention of Traditional Chinese Medicine Qushi Huayu Decoction on Rat Model of Fatty Liver Induced by High-Fat Diet
por: Gou, Xiao-jun, et al.
Publicado: (2019)

Serum and Liver Tissue Metabonomic Study on Fatty Liver in Rats Induced by High-Fat Diet and Intervention Effects of Traditional Chinese Medicine Qushi Huayu Decoction
por: Gou, Xiao-jun, et al.
Publicado: (2017)

Qushi Huayu decoction attenuated hepatic lipid accumulation via JAK2/STAT3/CPT-1A-related fatty acid β-oxidation in mice with non-alcoholic steatohepatitis
por: Sun, QinMei, et al.
Publicado: (2022)

Efficacy and safety of Qushi Huayu granule for hyperlipidemia: study protocol for a randomized, double-blind, placebo-controlled trial
por: Sun, Yuanlong, et al.
Publicado: (2022)

The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
por: Ni, Yiming, et al.
Publicado: (2022)

Acupuncture ameliorates breast cancer-related fatigue by regulating the gut microbiota-gut-brain axis
por: Lv, Zhuan, et al.
Publicado: (2022)

The immunomodulatory effects of Qushi Jianpi Hewei Decoction (QJHD) for patients with COVID-19 by metagenomics and transcriptomic sequencing
por: Li, Jinhui, et al.
Publicado: (2022)

Gynostemma pentaphyllum polysaccharides ameliorate non-alcoholic steatohepatitis in mice associated with gut microbiota and the TLR2/NLRP3 pathway
por: Yue, Si-Ran, et al.
Publicado: (2022)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
por: Silva, Ygor Parladore, et al.
Publicado: (2020)

Study on Intervention Mechanism of Yiqi Huayu Jiedu Decoction on ARDS Based on Network Pharmacology
por: Liang, Xu, et al.
Publicado: (2020)

Correlation Analysis of Huayu Tongmai Decoction Intervention and Prognosis Indexes of Patients with Carotid Atherosclerosis
por: Cheng, Guangqing, et al.
Publicado: (2021)

Yiqi Huayu decoction alleviates bleomycin-induced pulmonary fibrosis in rats by inhibiting senescence
por: Zuo, Biao, et al.
Publicado: (2022)

Seabuckthorn polysaccharide combined with astragalus polysaccharide ameliorate alcoholic fatty liver by regulating intestinal flora
por: Liu, Jiayue, et al.
Publicado: (2022)

Sini Decoction Ameliorates Colorectal Cancer and Modulates the Composition of Gut Microbiota in Mice
por: Wang, Yishan, et al.
Publicado: (2021)

Jiangtang Decoction Ameliorates Diabetic Kidney Disease Through the Modulation of the Gut Microbiota
por: Hong, Jinni, et al.
Publicado: (2023)

Bushen Wenyang Huayu Decoction Targets TLR4/NF-κB Mediated Autophagy to Treat Endometriosis Effectively
por: Li, Ying, et al.
Publicado: (2022)

The Effects of Erchen Decoction on Gut Microbiota and Lipid Metabolism Disorders in Zucker Diabetic Fatty Rats
por: Zhao, Tian, et al.
Publicado: (2021)

Gut microbiota short-chain fatty acids and their impact on the host thyroid function and diseases
por: Mendoza-León, María José, et al.
Publicado: (2023)

Effect of Yiqi Huayu Jiedu decoction on stages II and III gastric cancer: A multicenter, prospective, cohort study
por: Shu, Peng, et al.
Publicado: (2019)

In Vitro Antibacterial Experiment of Fuzheng Jiedu Huayu Decoction Against Multidrug-Resistant Pseudomonas aeruginosa
por: Xu, Hongri, et al.
Publicado: (2020)

Network Pharmacology Study and Experimental Validation of Yiqi Huayu Decoction Inducing Ferroptosis in Gastric Cancer
por: Song, Siyuan, et al.
Publicado: (2022)

Yiqi Jiedu Huayu Decoction Alleviates Renal Injury in Rats With Diabetic Nephropathy by Promoting Autophagy
por: Xuan, Chen, et al.
Publicado: (2021)

Electroacupuncture treatment ameliorates metabolic disorders in obese ZDF rats by regulating liver energy metabolism and gut microbiota
por: Ding, Lei, et al.
Publicado: (2023)

Wuzang Wenyang Huayu decoction regulates differentially expressed transcripts in the rats' hippocampus after cerebral hypoperfusion
por: Xia, Meng, et al.
Publicado: (2019)

Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine
por: Zhou, Zhijia, et al.
Publicado: (2022)

Polyphenol-rich Trapa quadrispinosa pericarp extract ameliorates high-fat diet induced non-alcoholic fatty liver disease by regulating lipid metabolism and insulin resistance in mice
por: Jian, Tunyu, et al.
Publicado: (2019)

Effects of Modified Jianpi Qushi Heluo Decoction on Scores of TCM Syndromes, 24 h Urinary Albumin, and Plasma Albumin in IMN of Spleen-Kidney Qi Deficiency
por: Wu, KaiPi, et al.
Publicado: (2022)

Non-alcoholic fatty liver and the gut microbiota
por: Bashiardes, Stavros, et al.
Publicado: (2016)

Intestinal Sensing by Gut Microbiota: Targeting Gut Peptides
por: Covasa, Mihai, et al.
Publicado: (2019)

“Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease
por: Guo, Kangxiao, et al.
Publicado: (2022)

Gancao Xiexin Decoction Ameliorates Ulcerative Colitis in Mice via Modulating Gut Microbiota and Metabolites
por: Luo, Yi-ting, et al.
Publicado: (2022)

Efficacy of Bushen Yiqi Huayu Decoction on Ovarian Reserve and Inflammatory Factors in Patients after Hysterectomy plus Salpingectomy
por: Zhang, Jinchun, et al.
Publicado: (2022)

Integrated network pharmacology and proteomics to reveal the cognitive improvement effect of Wuzang Wenyang Huayu decoction on vascular dementia
por: Sun, Yuhao, et al.
Publicado: (2022)

Editorial: Gut microbiota and gut-associated metabolites in bone health
por: Srivastava, Rupesh K., et al.
Publicado: (2023)

Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome
por: Zhou, Ling, et al.
Publicado: (2020)

Gut Microbiota and Energy Homeostasis in Fish
por: Butt, Robyn Lisa, et al.
Publicado: (2019)

Altered Gut Microbiota in Children With Hyperuricemia
por: Yuan, Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s1rd7j97c9c4hqbfevna00ojen